Schaumburg, Illinois, December 21, 2020—The Congress of Neurological Surgeons (CNS) has developed a new evidence-based guideline on neuroablative procedures for patients with cancer pain. An executive summary of the Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Neuroablative Procedures for Patients with Cancer Pain was published today in Neurosurgery. Other relevant information can also be found on the CNS Website.
This guideline is organized into four clinical cancer pain scenarios for ease of use and applicability in real clinical settings: unilateral somatic nociceptive/neuropathic body cancer pain, craniofacial cancer pain, midline subdiaphragmatic visceral cancer pain and disseminated cancer pain.
Dr. Ahmed Raslan, MD, the Guideline’s Task Force Chair, states, “neuroablative procedures for cancer pain remain an important and valuable tool to provide relief to suffering patients. The CNS supported the development of the first evidence-based guideline for Neuroablation for pain which will provide much needed support to neurosurgeons and physicians performing these procedures, ultimately helping a wide range of patients desperately in need for relief from intractable cancer pain”. This guideline was based on a literature review between January, 1980, to April, 2019. In accordance with the Institute of Medicine’s recommended best practice of reviewing guidelines every 5 years, the Congress of Neurological Surgeons is committed to ensuring timeliness and accuracy for its guidelines.
This guideline was developed by the CNS and endorsed by the CNS and the American Association of Neurological Surgeons.